AdaptHealth Corp. (AHCO) vs Design Therapeutics, Inc. (DSGN)
A side-by-side comparison of AdaptHealth Corp. and Design Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.78HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
DSGN
Design Therapeutics, Inc.
$11.92HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — AHCO vs DSGN
growth of $100 · dividends reinvested · last 6yAHCO -82.9% (-25.5%/yr)DSGN -70.1% (-18.2%/yr)DSGN compounded faster over this window
AHCO DSGN
AHCO vs DSGN: by the numbers
- •AHCO is the larger company ($786M vs $744M market cap).
- •Both run net losses; DSGN's is the smaller (0.00% vs -7.58% net margin).
Metrics side by side
Valuation
| Metric | AHCO | DSGN |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 0.57 | 3.69 |
| EV / EBITDA | 6.63 | N/A |
| FCF yield | 12.42% | N/A |
Profitability
| Metric | AHCO | DSGN |
|---|---|---|
| Gross margin | 10.37% | 0.00% |
| Operating margin | -0.31% | 0.00% |
| Net margin | -7.58% | 0.00% |
| ROE | -16.56% | -35.07% |
| ROIC | -0.26% | -38.92% |
Growth (annualized)
| Metric | AHCO | DSGN |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | N/A |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -3.82% |
Frequently asked
- How have AHCO and DSGN total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and DSGN delivered -3.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROEDesign Therapeutics ROEAdaptHealth operating marginDesign Therapeutics operating marginAdaptHealth revenue growthDesign Therapeutics revenue growthAdaptHealth free cash flowDesign Therapeutics free cash flow
AdaptHealth & Design Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.